Clock's ticking to July 14. $SRXH is sitting at the bottom of a 52-week range. Merger catalyst on deck. I mean… you do the math
Bullish thesis: NYSE accepted SRXH's compliance plan and extended its listing through July 14, 2026, removing the immediate delisting overhang that's the short-term catalyst window.
Dilution the real risk: A fresh prospectus disclosed plans to issue up to 418 million shares in connection with the pending EMJ Crypto Technologies merger. On top of that, the Series B preferred stock is convertible at a fixed price of $0.3182 per common share, with 22.2M accompanying warrants at the same exercise price. The good news: approximately 125,000,000 common-share equivalents were cancelled after the Series A preferred redemption in February, which was a structural positive.
Quick trade notes: Series B converts at $0.3182 nearly 3x the current price so any push toward that level could trigger selling pressure. The 418M merger shares are the dominant long-term overhang. Play the narrative, not the fundamentals, and have a hard exit plan. Not financial advice.